Statements (67)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Person
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Broad_Institute
|
| gptkbp:advocates_for |
Patient-centered care in oncology
|
| gptkbp:affiliation |
gptkb:Dana-Farber_Cancer_Institute
|
| gptkbp:awards |
gptkb:ASCO_Young_Investigator_Award
|
| gptkbp:clinical_trial |
Diversity in clinical trials
Patient engagement in research Palliative care in oncology Patient education in oncology Quality of life in cancer patients Patient safety in clinical trials Innovative treatment protocols Advocacy for cancer research funding Health disparities in cancer care Supportive care in cancer treatment Artificial intelligence in oncology Barriers to cancer care access Biomarkers in cancer treatment Biostatistics in clinical trials Clinical outcomes in cancer treatment Collaboration with patient advocacy groups Combination therapies for cancer Community outreach in cancer awareness Cultural competence in cancer care Data science in cancer research Digital health in cancer treatment Epidemiology of kidney cancer Ethical considerations in cancer research Genetic factors in kidney cancer Global health initiatives in cancer care Health economics in cancer care Immunotherapy approaches Impact of social determinants on health outcomes Innovations in surgical techniques for cancer Integrative oncology approaches Long-term effects of cancer therapies Multidisciplinary approaches in oncology Multiple kidney cancer trials Novel therapies for kidney cancer Patient navigation in oncology. Patient-reported outcomes in oncology Pharmacovigilance in cancer treatment Radiation therapy advancements Regulatory issues in oncology Survivorship issues in cancer Targeted therapies in oncology Telemedicine in oncology |
| gptkbp:collaborations |
Various international cancer research groups
|
| gptkbp:contribution |
Advancements in Immunotherapy
|
| gptkbp:education |
gptkb:Harvard_Medical_School
|
| gptkbp:grants |
gptkb:Police_Department
gptkb:Research_Institute Pharmaceutical companies |
| https://www.w3.org/2000/01/rdf-schema#label |
Toni K. Choueiri
|
| gptkbp:influence |
Kidney cancer treatment guidelines
|
| gptkbp:known_for |
Clinical Trials in Cancer
|
| gptkbp:location |
gptkb:Boston,_Massachusetts
|
| gptkbp:members |
gptkb:European_Society_for_Medical_Oncology
gptkb:American_Society_of_Clinical_Oncology |
| gptkbp:mentor |
Medical students and residents
|
| gptkbp:narrative_style |
Cancer journals
|
| gptkbp:notable_performers |
International cancer conferences
|
| gptkbp:profession |
gptkb:hospital
|
| gptkbp:publishes |
Numerous peer-reviewed articles
|
| gptkbp:research_focus |
gptkb:Kidney_Cancer
|
| gptkbp:specialization |
Genitourinary Oncology
|